At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Jun 9, 2026 at 13:24 ET
American Well filed a DEFA14A supplement to its 2026 proxy statement, announcing that co-founder Dr. Roy Schoenberg will not stand for re-election as a Class III director at the annual meeting and that the board will not nominate a substitute. This follows his recent resignation from the board on May 6, 2026, and the earlier resignation of director Dr. Peter Slavin, continuing a pattern of board turnover at the $146M market cap telehealth company.
- Dr. Roy Schoenberg, co-founder and former Executive Vice Chairman, will not stand for re-election as a Class III director at the 2026 annual meeting.
- The board will not nominate a substitute candidate for the vacant seat.
- Votes cast on Schoenberg's re-election proposal will not be counted.
- This follows Schoenberg's resignation from the board on May 6, 2026, and the earlier resignation of director Dr. Peter Slavin.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access